Neurological symptoms, including paralysis, experienced by Sjögren’s syndrome patients may not be caused by the disease but rather…
Ana Pena, PhD
Ana is a molecular biologist with a passion for discovery and communication. As a science writer she looks for connecting the public, in particular patient and healthcare communities, with clear and quality information about the latest medical advances. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in genetics, molecular biology, and infectious diseases.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Treatment with interferon-beta (IFN-β) reduces the inflammatory response in immune cells from Sjögren’s syndrome…
The average time for a patient to be diagnosed with Sjögren’s syndrome has been reduced from six to…
Monoclonal gammopathy, a condition marked by an unusual protein produced in plasma cells and one that can progress…